These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36150821)

  • 21. Toward automation of germline variant curation in clinical cancer genetics.
    Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
    Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research.
    Madhavan S; Ritter D; Micheel C; Rao S; Roy A; Sonkin D; Mccoy M; Griffith M; Griffith OL; Mcgarvey P; Kulkarni S
    Pac Symp Biocomput; 2018; 23():247-258. PubMed ID: 29218886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internal Standardization of the Interpretation and Reporting of Sequence Variants in Hematologic Neoplasms.
    Mehta N; He R; Viswanatha DS
    Mol Diagn Ther; 2021 Jul; 25(4):517-526. PubMed ID: 34125426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
    Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
    J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cruxome: a powerful tool for annotating, interpreting and reporting genetic variants.
    Han Q; Yang Y; Wu S; Liao Y; Zhang S; Liang H; Cram DS; Zhang Y
    BMC Genomics; 2021 Jun; 22(1):407. PubMed ID: 34082700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.
    Münz M; Ruark E; Renwick A; Ramsay E; Clarke M; Mahamdallie S; Cloke V; Seal S; Strydom A; Lunter G; Rahman N
    Genome Med; 2015 Jul; 7(1):76. PubMed ID: 26315209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.
    Duncavage EJ; Coleman JF; de Baca ME; Kadri S; Leon A; Routbort M; Roy S; Suarez CJ; Vanderbilt C; Zook JM
    J Mol Diagn; 2023 Jan; 25(1):3-16. PubMed ID: 36244574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing.
    Cushman-Vokoun A; Lauring J; Pfeifer J; Olson DR; Berry A; Thorson J; Voelkerding K; Myles J; Barbeau J; Chandra P; Li M; Vance GH; Jensen BW; Hansen MY; Yohe S
    Arch Pathol Lab Med; 2022 Jan; 146(1):70-77. PubMed ID: 33769456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
    Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation.
    Whiffin N; Walsh R; Govind R; Edwards M; Ahmad M; Zhang X; Tayal U; Buchan R; Midwinter W; Wilk AE; Najgebauer H; Francis C; Wilkinson S; Monk T; Brett L; O'Regan DP; Prasad SK; Morris-Rosendahl DJ; Barton PJR; Edwards E; Ware JS; Cook SA
    Genet Med; 2018 Oct; 20(10):1246-1254. PubMed ID: 29369293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
    Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.
    Lattante S; Marangi G; Doronzio PN; Conte A; Bisogni G; Zollino M; Sabatelli M
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32987860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer.
    Sukhai MA; Craddock KJ; Thomas M; Hansen AR; Zhang T; Siu L; Bedard P; Stockley TL; Kamel-Reid S
    Genet Med; 2016 Feb; 18(2):128-36. PubMed ID: 25880439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
    Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operationalizing Quality Assurance for Clinical Illumina Somatic Next-Generation Sequencing Pipelines.
    Bridgers J; Alexander K; Karsan A
    J Mol Diagn; 2024 Feb; 26(2):96-105. PubMed ID: 38086510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.
    Barnell EK; Waalkes A; Mosior MC; Penewit K; Cotto KC; Danos AM; Sheta LM; Campbell KM; Krysiak K; Rieke D; Spies NC; Skidmore ZL; Pritchard CC; Fehniger TA; Uppaluri R; Govindan R; Griffith M; Salipante SJ; Griffith OL
    JCO Clin Cancer Inform; 2019 Oct; 3():1-12. PubMed ID: 31618044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.
    Schrijver I; Aziz N; Farkas DH; Furtado M; Gonzalez AF; Greiner TC; Grody WW; Hambuch T; Kalman L; Kant JA; Klein RD; Leonard DG; Lubin IM; Mao R; Nagan N; Pratt VM; Sobel ME; Voelkerding KV; Gibson JS
    J Mol Diagn; 2012 Nov; 14(6):525-40. PubMed ID: 22918138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.